Clumped perinuclear BAP1 expression is a frequent finding in sporadic epithelioid Spitz tumors

被引:22
作者
Gammon, Bryan [1 ,2 ]
Traczyk, Tom N. [1 ]
Gerami, Pedram [1 ]
机构
[1] Northwestern Univ, Sch Med, Dept Dermatol, Chicago, IL 60611 USA
[2] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA
关键词
immunohistochemical method; melanocytic lesions; melanoma; nevus with architectural disorder; BRCA1-ASSOCIATED PROTEIN-1; CELL-GROWTH; MUTATION; PREDISPOSE;
D O I
10.1111/cup.12133
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background BRCA1-associated protein 1 (BAP1) represents a recently identified tumor suppressor protein. Loss of BAP1 has been observed in cutaneous epithelioid Spitz tumors. These cutaneous melanocytic tumors show a distinct histopathologic phenotype characterized by an intradermal sheet-like proliferation of epithelioid melanocytes. Methods We retrospectively reviewed the clinical outcomes, histopathologic findings and immunophenotype in spitzoid melanocytic neoplasms with the morphologic features seen in BAP1 mutated Spitz tumors. Cases were obtained from our files. BAP1 immunohistochemistry was evaluated dichotomously for the presence of nuclear staining. Results Fifteen of 19 cases showed loss of nuclear BAP1 expression. Of the 15 cases displaying nuclear loss of BAP1, clumped perinuclear staining was observed in 8 cases while 7 cases showed complete loss. Follow up ranging from 045months (mean 17months) was uneventful. Conclusions Our data are consistent with an indolent overall clinical course for epithelioid Spitz tumors with loss of BAP1. Furthermore, a large subset of epithelioid Spitz tumors display loss of nuclear expression but show a reproducible clumped perinuclear staining pattern.
引用
收藏
页码:538 / 542
页数:5
相关论文
共 38 条
  • [21] Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series
    Aung, Phyu P.
    Nagarajan, Priyadharsini
    Tetzlaff, Michael T.
    Curry, Jonathan L.
    Tang, Guilin
    Abdullaev, Zied
    Pack, Svetlana D.
    Ivan, Doina
    Prieto, Victor G.
    Torres-Cabala, Carlos A.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2019, 41 (03) : 167 - 176
  • [22] Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma
    Farquhar, Neil
    Thornton, Sophie
    Coupland, Sarah E.
    Coulson, Judy M.
    Sacco, Joseph J.
    Krishna, Yamini
    Heimann, Heinrich
    Taktak, Azzam
    Cebulla, Colleen M.
    Abdel-Rahman, Mohamed H.
    Kalirai, Helen
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2018, 4 (01) : 26 - 38
  • [23] Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer
    Hirosawa, Takashi
    Ishida, Masaharu
    Ishii, Kentaro
    Kanehara, Keigo
    Kudo, Katsuyoshi
    Ohnuma, Shinobu
    Kamei, Takashi
    Motoi, Fuyuhiko
    Naitoh, Takeshi
    Selaru, Florin M.
    Unno, Michiaki
    PLOS ONE, 2018, 13 (11):
  • [24] BAP1 Loss is a Useful Adjunct to Distinguish Malignant Mesothelioma Including the Adenomatoid-like Variant From Benign Adenomatoid Tumors
    Erber, Ramona
    Warth, Arne
    Muley, Thomas
    Hartmann, Arndt
    Herpel, Esther
    Agaimy, Abbas
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (01) : 67 - 73
  • [25] BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy
    Soares de Sa, Bianca Costa
    de Macedo, Mariana Petaccia
    Torrezan, Giovana Tardin
    Tavoloni Braga, Juliana Casagrande
    Fidalgo, Felipe
    Moredo, Luciana Facure
    Lellis, Rute
    Duprat, Joao Pereira
    Carraro, Dirce Maria
    BMC CANCER, 2019, 19 (01)
  • [26] Inference on Germline BAP1 Mutations and Asbestos Exposure from the Analysis of Familial and Sporadic Mesothelioma in a High-Risk Area
    Betti, Marta
    Casalone, Elisabetta
    Ferrante, Daniela
    Romanelli, Antonio
    Grosso, Federica
    Guarrera, Simonetta
    Righi, Luisella
    Vatrano, Simona
    Pelosi, Giuseppe
    Libener, Roberta
    Mirabelli, Dario
    Boldorini, Renzo
    Casadio, Caterina
    Papotti, Mauro
    Matullo, Giuseppe
    Magnani, Corrado
    Dianzani, Irma
    GENES CHROMOSOMES & CANCER, 2015, 54 (01) : 51 - 62
  • [27] Protein and mRNA Expression in Uveal Melanoma Cell Lines Are Related to GNA and BAP1 Mutation Status
    Gelmi, Maria Chiara
    de Ru, Arnoud H.
    van Veelen, Peter A.
    Tjokrodirijo, Rayman T. N.
    Stern, Marc-Henri
    Houy, Alexandre
    Verdijk, Robert M.
    Vu, T. H. Khanh
    Ksander, Bruce R.
    Vaarwater, Jolanda
    Kilic, Emine
    Brosens, Erwin
    Jager, Martine J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (08)
  • [28] Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies
    Yan, Yu-Chuan
    Meng, Guang-Xiao
    Ding, Zi-Niu
    Liu, Yan-Feng
    Chen, Zhi-Qiang
    Yan, Lun-Jie
    Yang, Ya-Fei
    Liu, Hui
    Yang, Chun-Cheng
    Dong, Zhao-Ru
    Hong, Jian-Guo
    Li, Tao
    JOURNAL OF CANCER, 2022, 13 (01): : 88 - 101
  • [29] Prediction of BAP1 Expression in Uveal Melanoma Using Densely-Connected Deep Classification Networks
    Sun, Muyi
    Zhou, Wei
    Qi, Xingqun
    Zhang, Guanhong
    Girnita, Leonard
    Seregard, Stefan
    Grossniklaus, Hans E.
    Yao, Zeyi
    Zhou, Xiaoguang
    Stalhammar, Gustav
    CANCERS, 2019, 11 (10)
  • [30] Balanced Epigenetic Regulation of MHC Class I Expression in Tumor Cells by the Histone Ubiquitin Modifiers BAP1 and PCGF1
    Wijdeven, Ruud H.
    Luk, Sietse J.
    Schoufour, Tom A. W.
    Zanden, Sabina Y. van der
    Cabezuelo, Marta
    Heemskerk, Mirjam H. M.
    Neefjes, Jacques
    JOURNAL OF IMMUNOLOGY, 2024, 212 (03) : 446 - 454